Evidence map›Paper›PMID 37987768›Full record

ArticleAnalytical and bioanalytical chemistry2024

A novel 2-(2-aminophenyl) imidazo [1,5-a] pyridine-based fluorescent probe for rapid detection of phosgene.

Xiaojian Kong, Jie Zhao, Lei Yang, Feng Wang, Zhiwei Sun

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xiaojian KongSchool of Chemistry, Chemical Engineering and Materials, Jining University, Qufu, 273155, China. kongmhz@163.com.
Jie ZhaoKey Laboratory of Life-Organic Analysis of Shandong Province, Qufu Normal University, Qufu, China.
Lei YangKey Laboratory of Life-Organic Analysis of Shandong Province, Qufu Normal University, Qufu, China.
Feng WangKey Laboratory of Life-Organic Analysis of Shandong Province, Qufu Normal University, Qufu, China.
Zhiwei SunKey Laboratory of Life-Organic Analysis of Shandong Province, Qufu Normal University, Qufu, China. zhiweisun@qfnu.edu.cn.
Qufu Normal University · CNJining University · CN

Funding

College Students of Qufu Normal University XJ20200003Natural Science Foundation of Shandong Province ZR2019MB005
6 · The paper itself

Abstract

Phosgene is a highly concealed and highly toxic gas that seriously threatens human health and public security. Therefore, the detection of phosgene is of great significance to world security. Herein, a new type of fluorescent probe based on 2-(2-aminophenyl) imidazo [1,5-a] pyridine is reported for the rapid detection of phosgene. The probe itself only emits a faint green fluorescence, while phosgene allows it to produce a strong blue fluorescence. During the recognition process, phosgene interacts simultaneously with both amino site and imidazole moiety in the probe molecule, resulting in a four-ring-fused rigid structure with high fluorescence quantum yield. The probe not only has the characteristics of high efficiency, high sensitivity (detection limit 2.68 nM), and high selectivity, but also has remarkable spectral changes. Finally, a portable test strip is used to detect phosgene in the gas phase, and the fluorescent color change of the test strip can be easily observed. The most exciting thing is that the portable test strip with the probe PMPY-NH

Indexed as

2-(2-Aminophenyl) imidazo [1,5-a] pyridineFluorescent probePhosgeneTurn-on

Identifiers

PMID37987768
OpenAlexW4388845628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.